| Details |
| Disease Name | Pituitary Neoplasms |
| Nocoding RNA Name | hsa-miR-93 |
| Expression Pattern | up-regulated |
| Species | Homo sapiens |
| Detection Methods | qRT-PCR,Luciferase Reporter Assay etc. |
| Target | p21 |
| Tissue | brain(pituitary tissues) |
| Treatment | bromocriptine |
| PubMed ID | 25064468 |
| Year | 2014 |
| Detail Description | 12 of these were validated by stem-loop qRT-PCR. Hsa-mir-93, hsa-mir-17, hsa-mir-22*, hsa-mir-126*, hsa-mir-142-3p, hsa-mir-144*, hsa-mir-486-5p, hsa-mir-451, and hsa-mir-92a were up-regulated and hsa-mir-30a, hsa-mir-382, and hsa-mir-136 were down-regulated in bromocriptine-resistant prolactinomas in comparison with bromocriptine-sensitive prolactinomas.Mir-93 directly affected p21 expression in MMQ cells by targeting the 3′-UTR. |
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback
© All right reserved 2016